Provided by Tiger Fintech (Singapore) Pte. Ltd.

Becton Dickinson

227.64
+0.14230.06%
Volume:843.70K
Turnover:191.58M
Market Cap:65.36B
PE:38.31
High:228.59
Open:226.93
Low:225.12
Close:227.50
Loading ...

BD Named One of America's Most Innovative Companies by Fortune

PR Newswire
·
Yesterday

Shareholders in GSH (SGX:BDX) have lost 18%, as stock drops 11% this past week

Simply Wall St.
·
29 Mar

Here’s What Positions Becton, Dickinson and Company (BDX) Favorably in the Health Care Sector

Insider Monkey
·
28 Mar

BRIEF-BD Names Gregory J. Hayes To Board Of Directors

Reuters
·
28 Mar

Bd Names Gregory J. Hayes to Board of Directors

THOMSON REUTERS
·
28 Mar

Press Release: BD Names Gregory J. Hayes to Board of Directors

Dow Jones
·
28 Mar

Goldman Sachs Adjusts PT to Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating

MT Newswires Live
·
27 Mar

BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone

Zacks
·
24 Mar

Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term

Zacks
·
21 Mar

BRIEF-FDA Says Bard Peripheral Vascular Issued Letter To Affected Customers On Rotarex Atherectomy Systems Usage

Reuters
·
21 Mar

FDA: Identified Bard Peripheral Vascular's Atherectomy Catheter System Recall as the Most Serious Type

THOMSON REUTERS
·
21 Mar

FDA: Bd Reported 115 Cases Requiring Additional Intervention Following Helix Fracture and/or Breakage Related to Atherectomy Catheter System Issue

THOMSON REUTERS
·
21 Mar

FDA: Aware Bard Peripheral Vascular Issued Letter to Affected Customers Providing Updated Instructions for Use for Rotarex Atherectomy Systems

THOMSON REUTERS
·
21 Mar

Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial

MT Newswires Live
·
20 Mar

Becton Dickinson announces first patient treated in GalaFLEX trial

TIPRANKS
·
20 Mar

Bd Announces Milestone in Clinical Trial for Use of Bioabsorbable Galaflex Lite™ Scaffold in Breast Implant Revision Surgery

THOMSON REUTERS
·
20 Mar